Purus Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,192
Closed -$202K 173
2026
Q1
$202K Buy
+7,192
New +$191K 0.06% 155
2025
Q3
Sell
-8,739
Closed -$212K 147
2025
Q2
$212K Buy
+8,739
New +$204K 0.07% 133
2023
Q1
Sell
-4,311
Closed -$221K 113
2022
Q4
$221K Buy
+4,311
New +$207K 0.2% 100
2022
Q3
Sell
-4,304
Closed -$226K 105
2022
Q2
$226K Buy
+4,304
New +$219K 0.2% 93

Other funds holding PFE

Purus Wealth Management's PFE Position: Q2 2026 in Review

Purus Wealth Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,192 shares — an estimated $202K sold.

Purus Wealth Management first reported a position in PFE in Q2 2022 and held it in 4 quarters. The position peaked at $226K in Q2 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Purus Wealth Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Purus Wealth Management sold 7,192 Pfizer shares in Q2 2026, an estimated $202K.
  • Purus Wealth Management first reported a position in Pfizer in Q2 2022 and held it in 4 quarters.
  • Purus Wealth Management's Pfizer position peaked at $226K in Q2 2022.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Purus Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.